DE69840445D1 - Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv - Google Patents

Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv

Info

Publication number
DE69840445D1
DE69840445D1 DE69840445T DE69840445T DE69840445D1 DE 69840445 D1 DE69840445 D1 DE 69840445D1 DE 69840445 T DE69840445 T DE 69840445T DE 69840445 T DE69840445 T DE 69840445T DE 69840445 D1 DE69840445 D1 DE 69840445D1
Authority
DE
Germany
Prior art keywords
hiv
antigen constructs
group
distinction
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840445T
Other languages
English (en)
Inventor
John R Hackett
Julie Yamaguchi
Alan M Golden
Catherine Brennan
Robert K Hickman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69840445D1 publication Critical patent/DE69840445D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69840445T 1997-08-15 1998-08-17 Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv Expired - Lifetime DE69840445D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/911,824 US6846905B2 (en) 1997-08-15 1997-08-15 Antigen constructs useful in the detection and differentiation of antibodies to HIV
PCT/US1998/017014 WO1999009179A2 (en) 1997-08-15 1998-08-17 Antigen constructs useful in the detection and differentiation of antibodies to hiv

Publications (1)

Publication Number Publication Date
DE69840445D1 true DE69840445D1 (de) 2009-02-26

Family

ID=25430915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840445T Expired - Lifetime DE69840445D1 (de) 1997-08-15 1998-08-17 Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv

Country Status (8)

Country Link
US (6) US6846905B2 (de)
EP (3) EP2305818B1 (de)
JP (3) JP4394827B2 (de)
AT (1) ATE420183T1 (de)
CA (1) CA2300360C (de)
DE (1) DE69840445D1 (de)
ES (3) ES2320053T3 (de)
WO (1) WO1999009179A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846905B2 (en) * 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
WO2000004383A2 (en) * 1998-07-14 2000-01-27 Abbott Laboratories Hiv group o positive control
KR100614714B1 (ko) * 2001-06-15 2006-08-21 에프. 호프만-라 로슈 아게 ｇｐ41 단편의 아세틸화
EP2292772A1 (de) * 2001-07-05 2011-03-09 Novartis Vaccines and Diagnostics, Inc. HIV Impfung mit für ein HIV Polypeptid kodierender DNS und einem HIV Polypeptid
EP2362310B1 (de) * 2005-03-16 2017-10-04 III Holdings 12, LLC Automatische Arbeitslastübertragung auf ein On-Demand-Center
DE102006012885A1 (de) * 2006-03-18 2007-09-20 Institut Virion/Serion Gmbh Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial
US20110262474A1 (en) * 2007-07-23 2011-10-27 Xiaohan Du Chimeric HIV Antigens
FR2935246B1 (fr) * 2008-08-29 2010-09-03 Seb Sa Article culinaire comportant un revetement antiadhesif a proprietes ameliorees d'anti-adherence
EP2206801A1 (de) * 2008-12-24 2010-07-14 Seb Sa Verbundstoff-Kochgeschirr mit einer glasartigen Schutzbeschichtung
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
WO2011103185A1 (en) 2010-02-16 2011-08-25 Catherine A Brennan Human group p immunodeficiency virus and uses thereof
US9551714B2 (en) 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
MX2015012824A (es) 2013-03-14 2016-06-24 Abbott Lab Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
MX2015012825A (es) 2013-03-14 2016-06-10 Abbott Lab Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
WO2014158272A1 (en) 2013-03-14 2014-10-02 Abbott Laboratories Hcv antigen-antibody combination assay and methods and compositions for use therein

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US5853978A (en) * 1985-12-04 1998-12-29 Genentech, Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
US5391485A (en) 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US4839288A (en) 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US5071972A (en) 1986-01-31 1991-12-10 Genetics Institute, Inc. DNA sequences encoding novel thrombolytic proteins
US4925784A (en) 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
EP0273115B1 (de) 1986-10-22 1994-09-07 Abbott Laboratories Chemilumineszierende Acridinium- und Phenantridiniumsalze
EP0276846A3 (de) 1987-01-29 1989-07-26 Zymogenetics, Inc. Derivate des koloniestimulierenden Faktors
US5254458A (en) 1987-10-30 1993-10-19 Abbott Laboratories Immunoassays using antigens produced in heterologous organisms
EP0317804B1 (de) 1987-11-24 1995-10-04 Abbott Laboratories HIV-Peptide und Methoden für den Nachweis von HIV
AU609241B2 (en) 1988-01-29 1991-04-26 Abbott Laboratories Ion-capture assays and devices
US5322769A (en) 1988-03-11 1994-06-21 Abbott Laboratories Methods for using CKS fusion proteins
US5124255A (en) 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
EP0657532B1 (de) 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 Retrovirusstämmen sowie ihre Verwendung
ATE141946T1 (de) 1988-06-14 1996-09-15 Qiagen Gmbh Hiv-2-virusvarianten
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
DK0425633T3 (da) 1989-04-14 1994-11-28 Procedes Petroliers Petrochim Fremgangsmåde til dampfasekrakning af carbonhydrider
CA1341592C (en) 1989-07-07 2009-04-14 Abbott Laboratories Ion capture reagents and methods for performing binding assays
IE904083A1 (en) 1989-11-13 1991-05-22 Cambridge Biotech Corp Diagnostic proteins to test for more than one antibody
EP0473065A3 (en) 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
DK0591914T4 (da) 1992-10-06 2010-05-25 Siemens Healthcare Diagnostics Retrovirus fra HIV-gruppen og dets anvendelse
WO1994023069A1 (en) 1993-03-26 1994-10-13 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
CA2161872A1 (en) 1994-03-02 1995-09-08 James L. Gallarda Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
JP2803020B2 (ja) 1994-05-06 1998-09-24 ダイナボット株式会社 Ｈｉｖ関連抗体測定法
GB9410044D0 (en) 1994-05-19 1994-07-06 Int Murex Tech Corp Assay
DK0787191T4 (da) 1994-10-20 2012-01-30 Pasteur Institut Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener
US5599662A (en) 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US6846905B2 (en) * 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US5922533A (en) 1997-08-15 1999-07-13 Abbott Laboratories Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
US9817014B2 (en) 2013-06-03 2017-11-14 Mnemonics, Inc. Saw-based tachometer or RPM detector

Also Published As

Publication number Publication date
EP2055780A3 (de) 2009-09-16
US20080090994A1 (en) 2008-04-17
US20060153866A1 (en) 2006-07-13
JP5255998B2 (ja) 2013-08-07
EP1003879B1 (de) 2009-01-07
EP2305818A2 (de) 2011-04-06
EP1003879A1 (de) 2000-05-31
US20110091868A1 (en) 2011-04-21
US20030004323A1 (en) 2003-01-02
JP4394827B2 (ja) 2010-01-06
JP2012105649A (ja) 2012-06-07
US20080090226A1 (en) 2008-04-17
US7883845B2 (en) 2011-02-08
WO1999009179A3 (en) 2003-05-08
US20100035237A1 (en) 2010-02-11
ES2446271T3 (es) 2014-03-06
ES2485292T3 (es) 2014-08-13
US7615614B2 (en) 2009-11-10
CA2300360A1 (en) 1999-02-25
EP2055780B1 (de) 2013-11-27
US7615613B2 (en) 2009-11-10
EP2055780A2 (de) 2009-05-06
EP2305818A3 (de) 2011-05-11
WO1999009179A2 (en) 1999-02-25
US7619061B2 (en) 2009-11-17
EP2305818B1 (de) 2014-06-04
US8785596B2 (en) 2014-07-22
ES2320053T3 (es) 2009-05-18
JP2003525014A (ja) 2003-08-26
ATE420183T1 (de) 2009-01-15
US6846905B2 (en) 2005-01-25
CA2300360C (en) 2010-01-12
JP2009106289A (ja) 2009-05-21
JP5498473B2 (ja) 2014-05-21

Similar Documents

Publication Publication Date Title
DE69840445D1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
DK53687D0 (da) Peptid_fra htlv-iii-viruskappeprotein
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DK0891982T3 (da) HIV-peptider
CY1105282T1 (el) Διαγνωση της κοιλιοκακης με τη χρηση ενος επιτοπιου της γλιαδινης
TR200100163T2 (tr) Güçlendirilmiş farmakokinetik özelliklere sahip hibrid polipeptidler
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DK261386A (da) Monoklonale antistoffer
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DK0787191T3 (da) Nukleotidsekvenser som koder for antigener fra HIV-1-retrovirus gruppe (eller undergruppe) O, transmembrane kappepeptider og retoviruscapsidproteiner og -peptider
DE69130396D1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
ATE119200T1 (de) Erhöhte produktion von proteinen in bakterien durch verwendung einer neuen ribosombindungsstelle.
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
DE69728897D1 (de) Saeugetierchemokine
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
ATE294237T1 (de) S?ugetier thymokingene
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE69433787D1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung
AR015659A1 (es) Un procedimiento para la deteccion de anticuerpos contra el hiv y antigenos usados en el mismo.
DK0851872T3 (da) TLP-komplekspeptider fra urogentiale carcinomer og antistoffer deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition